Global Buccal Drug Delivery System Market Analysis 2026–2030 With Strategic Insights
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Buccal Drug Delivery System Market Over The 2026–2030 Period?
The market for buccal drug delivery systems has experienced rapid expansion recently. Projections indicate a rise from $3.89 billion in 2025 to $4.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.2%. This historical growth is primarily due to factors such as a growing preference for alternative drug delivery methods, an increase in treatments for chronic pain and angina, developments in mucoadhesive formulations, a heightened need for quicker-acting medications, and the expansion of oral pharmaceutical production.
The market for buccal drug delivery systems is anticipated to experience substantial expansion in the coming years. This market is projected to reach $6.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the forecast period include greater investments in transmucosal drug research, an uptick in the demand for smoking cessation therapies, the broadening of personalized drug delivery systems, an intensified focus on compliance-friendly formulations, and the increased development of new buccal drugs. Key trends anticipated during this period involve a wider embrace of buccal and sublingual dosage forms, a growing need for swift drug absorption systems, an enhanced emphasis on patient-centric drug delivery, the enlargement of controlled-release buccal formulations, and a heightened focus on non-invasive therapies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
Which Important Drivers Are Guiding The Buccal Drug Delivery System Market Growth?
The growing occurrence of chronic illnesses is anticipated to fuel the expansion of the buccal drug delivery systems market in the future. Chronic diseases are defined as conditions that endure for at least a year, encompassing ailments such as cancer, heart disease, stroke, diabetes, and arthritis. These widespread chronic conditions, though manageable, are incurable and demand ongoing nutritional and medical attention. Buccal drug delivery systems offer suitable and efficient means for delivering mucosal and transmucosal medications, essential for numerous patients battling chronic ailments like diabetes and cancer. As an illustration, in June 2024, data from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) had been diagnosed with non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, insufficient for a diabetes classification) in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the increasing incidence of chronic diseases is a significant impetus for the expansion of the buccal drug delivery systems market.
How Are Different Segments Classified In The Buccal Drug Delivery System Market Segment Analysis?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
What Trends Are Influencing The Evolution Of The Buccal Drug Delivery System Market?
Major companies in the buccal drug delivery systems market are concentrating on launching new products, such as melatonin oral spray, to increase their revenue. Melatonin oral spray is a form of melatonin supplementation designed for oral use in a spray format. For instance, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical company, launched a melatonin oral spray. This spray supports the body’s natural production of melatonin, thereby enhancing sleep quality in an easy and effective manner. This medication offers a quick solution for those facing challenges with falling asleep, staying asleep, or adjusting to different sleep regimens. The spray’s rapid and easy oral absorption facilitates a quicker initiation of sleep and improved sleep quality.
Who Are The Companies Driving Activity In The Buccal Drug Delivery System Market?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc
Get The Full Buccal Drug Delivery System Market Report:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Which Region Holds The Highest Market Share In The Buccal Drug Delivery System Market?
North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Buccal Drug Delivery System Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp
Browse Through More Reports Similar to the Global Buccal Drug Delivery System Market 2026, By The Business Research Company
Gastroretentive Drug Delivery Systems Outsourcing Market Report 2026
Pharmaceutical Drug Delivery Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Advanced Drug Delivery Systems Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
